Annual Non Current Assets
$16.76 M
+$5.75 M+52.22%
December 31, 2023
Summary
- As of February 7, 2025, YMAB annual long term assets is $16.76 million, with the most recent change of +$5.75 million (+52.22%) on December 31, 2023.
- During the last 3 years, YMAB annual non current assets has risen by +$7.07 million (+73.05%).
- YMAB annual non current assets is now at all-time high.
Performance
YMAB Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$21.86 M
+$4.59 M+26.56%
September 30, 2024
Summary
- As of February 7, 2025, YMAB quarterly long term assets is $21.86 million, with the most recent change of +$4.59 million (+26.56%) on September 30, 2024.
- Over the past year, YMAB quarterly non current assets has increased by +$5.10 million (+30.45%).
- YMAB quarterly non current assets is now at all-time high.
Performance
YMAB Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
YMAB Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +52.2% | +30.4% |
| 3 y3 years | +73.0% | +98.6% |
| 5 y5 years | +4175.0% | +98.6% |
YMAB Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +59.3% | at high | +107.8% |
| 5 y | 5-year | at high | +279.9% | at high | +445.3% |
| alltime | all time | at high | -100.0% | at high | +6145.7% |
Y-mAbs Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $21.86 M(+26.6%) |
| Jun 2024 | - | $17.27 M(+14.8%) |
| Mar 2024 | - | $15.05 M(-10.2%) |
| Dec 2023 | $111.11 M(-14.8%) | $16.76 M(+19.5%) |
| Sep 2023 | - | $14.02 M(-15.6%) |
| Jun 2023 | - | $16.61 M(+23.6%) |
| Mar 2023 | - | $13.44 M(+22.1%) |
| Dec 2022 | $130.45 M(-35.5%) | $11.01 M(+3.2%) |
| Sep 2022 | - | $10.67 M(-5.2%) |
| Jun 2022 | - | $11.26 M(-15.4%) |
| Mar 2022 | - | $13.31 M(+26.5%) |
| Dec 2021 | $202.26 M | $10.52 M(+11.9%) |
| Sep 2021 | - | $9.40 M(-7.0%) |
| Jun 2021 | - | $10.11 M(-7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $10.91 M(+12.6%) |
| Dec 2020 | $122.36 M(-42.3%) | $9.68 M(-3.0%) |
| Sep 2020 | - | $9.99 M(+149.1%) |
| Jun 2020 | - | $4.01 M(-5.4%) |
| Mar 2020 | - | $4.24 M(-3.9%) |
| Dec 2019 | $211.96 M(+39.9%) | $4.41 M(+7.8%) |
| Sep 2019 | - | $4.09 M(+43.6%) |
| Jun 2019 | - | $2.85 M(-3.8%) |
| Mar 2019 | - | $2.96 M(+655.9%) |
| Dec 2018 | $151.53 M(+65.9%) | $392.00 K(+12.0%) |
| Sep 2018 | - | $350.00 K(-77.7%) |
| Jun 2018 | - | $1.57 M(+103.2%) |
| Dec 2017 | $91.36 M(+429.3%) | $772.00 K |
| Dec 2016 | $17.26 M | - |
FAQ
- What is Y-mAbs Therapeutics annual long term assets?
- What is the all time high annual non current assets for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual non current assets year-on-year change?
- What is Y-mAbs Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly non current assets year-on-year change?
What is Y-mAbs Therapeutics annual long term assets?
The current annual non current assets of YMAB is $16.76 M
What is the all time high annual non current assets for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual long term assets is $16.76 M
What is Y-mAbs Therapeutics annual non current assets year-on-year change?
Over the past year, YMAB annual long term assets has changed by +$5.75 M (+52.22%)
What is Y-mAbs Therapeutics quarterly long term assets?
The current quarterly non current assets of YMAB is $21.86 M
What is the all time high quarterly non current assets for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly long term assets is $21.86 M
What is Y-mAbs Therapeutics quarterly non current assets year-on-year change?
Over the past year, YMAB quarterly long term assets has changed by +$5.10 M (+30.45%)